SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001267602-19-000106
Filing Date
2019-08-06
Accepted
2019-08-06 16:31:56
Documents
69
Period of Report
2019-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q alim-6301910q.htm 10-Q 1239602
2 EXHIBIT 31.1 alimera-10xqexhibit31163019.htm EX-31.1 22233
3 EXHIBIT 31.2 alimera-10xqexhibit31263019.htm EX-31.2 21497
4 EXHIBIT 32.1 alimera-10xqexhibit32163019.htm EX-32.1 7869
  Complete submission text file 0001267602-19-000106.txt   6601136

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT alim-20190630.xml EX-101.INS 1459181
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT alim-20190630.xsd EX-101.SCH 47888
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT alim-20190630_cal.xml EX-101.CAL 82342
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT alim-20190630_def.xml EX-101.DEF 218163
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT alim-20190630_lab.xml EX-101.LAB 638600
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT alim-20190630_pre.xml EX-101.PRE 368214
Mailing Address 6120 WINDWARD PARKWAY STE 290 ALPHARETTA GA 30005
Business Address 6120 WINDWARD PARKWAY STE 290 ALPHARETTA GA 30005 678-990-5740
ALIMERA SCIENCES INC (Filer) CIK: 0001267602 (see all company filings)

IRS No.: 200028718 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-34703 | Film No.: 191002528
SIC: 2834 Pharmaceutical Preparations